Are bone morphogenetic proteins effective inducers of cartilage repair? Ex vivo transduction of muscle-derived stem cells

Arthritis and Rheumatism

Volumn 54, Issue 2, 2006, Pages 387-389

  Goldring, Mary B ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN;

CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL TRANSPLANTATION; EDITORIAL; HUMAN; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL; TISSUE REPAIR;

BONE MORPHOGENETIC PROTEINS; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; CHONDROGENESIS; HUMANS; MESENCHYMAL STEM CELLS; MUSCLE, SKELETAL; REGENERATION; TRANSDUCTION, GENETIC;

EID: 32444439329     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21756     Document Type: Editorial

References (30)

1. Yoon BS, Lyons KM. Multiple functions of BMPs in chondrogenesis [review]. J Cell Biochem 2004;93:93-103.
2. Niswander L. Pattern formation: old models out on a limb [review]. Nat Rev Genet 2003;4:133-43.
3. Goldring MB, Tsuchimochi K, Ijiri K. The control of chondrogenesis. J Cell Biochem 2005. In press.
4. Kuroda R, Usas A, Kubo S, Corsi K, Peng H, Rose T, et al. Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum 2005;54:433-42.
5. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994;331:889-95.
6. Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization [review]. Int J Biochem Cell Biol 2004;36:568-84.
7. Caplan AI. Mesenchymal stem cells: cell-based reconstructive therapy in orthopedics [review]. Tissue Eng 2005;11:1198-211.
8. Urist MR. Bone: formation by autoinduction. Science 1965;150:893-9.
9. Friedenstein AJ, Piatetzky S II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 1966;16:381-90.
10. Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy [review]. J Cell Biochem 1994;56:283-94.
11. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7.
12. Tuan RS. Biology of developmental and regenerative skeletogenesis [review]. Clin Orthop Relat Res 2004(427 Suppl):S105-17.
13. Park J, Gelse K, Frank S, von der Mark K, Aigner T, Schneider H. Transgene-activated mesenchymal cells for articular cartilage repair: a comparison of primary bone marrow-, perichondrium/periosteum- and fat-derived cells. J Gene Med 2005. In press.
14. Shen HC, Peng H, Usas A, Gearhart B, Cummins J, Fu FH, et al. Ex vivo gene therapy-induced endochondral bone formation: comparison of muscle-derived stem cells and different subpopulations of primary muscle-derived cells. Bone 2004;34:982-92.
15. Adachi N, Sato K, Usas A, Fu FH, Ochi M, Han CW, et al. Muscle derived, cell based ex vivo gene therapy for treatment of full thickness articular cartilage defects. J Rheumatol 2002;29:1920-30.
16. Sellers RS, Zhang R, Glasson SS, Kim HD, Peluso D, D'Augusta DA, et al. Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2). J Bone Joint Surg Am 2000;82:151-60.
17. Cook SD, Patron LP, Salkeld SL, Rueger DC. Repair of articular cartilage defects with osteogenic protein-1 (BMP-7) in dogs. J Bone Joint Surg Am 2003;85-A Suppl 3:116-23.
18. Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, et al. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am 1994;76:579-92.
19. Hunziker EB. Articular cartilage repair: basic science and clinical progress: a review of the current status and prospects [review]. Osteoarthritis Cartilage 2002;10:432-63.
20. Breinan HA, Hsu HP, Spector M. Chondral defects in animal models: effects of selected repair procedures in canines. Clin Orthop Relat Res 2001(391 Suppl):S219-30.
21. Buma P, Pieper JS, van Tienen T, van Susante JL, van der Kraan PM, Veerkamp JH, et al. Cross-linked type I and type II collagenous matrices for the repair of full-thickness articular cartilage defects: a study in rabbits. Biomaterials 2003;24:3255-63.
22. Knutsen G, Engebretsen L, Ludvigsen TC, Drogset JO, Grontvedt T, Solheim E, et al. Autologous chondrocyte implantation compared with microfracture in the knee: a randomized trial. J Bone Joint Surg Am 2004;86-A:455-64.
23. Seeherman H, Wozney JM. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 2005;16:329-45.
24. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 2005;52:2521-9.
25. Huang JI, Kazmi N, Durbhakula MM, Hering TM, Yoo JU, Johnstone B. Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: a patient-matched comparison. J Orthop Res 2005;23:1383-9.
26. Park Y, Sugimoto M, Watrin A, Chiquet M, Hunziker EB. BMP-2 induces the expression of chondrocyte-specific genes in bovine synovium-derived progenitor cells cultured in three-dimensional alginate hydrogel. Osteoarthritis Cartilage 2005;13:527-36.
27. Hills RL, Belanger LM, Morris EA. Bone morphogenetic protein 9 is a potent anabolic factor for juvenile bovine cartilage, but not adult cartilage. J Orthop Res 2005;23:611-7.
28. Tcacencu I, Carlsoo B, Stierna P. Effect of recombinant human BMP-2 on the repair of cricoid cartilage defects in young and adult rabbits: a comparative study. Int J Pediatr Otorhinolaryngol 2005;69:1239-46.
29. Murphy JM, Dixon K, Beck S, Fabian D, Feldman A, Barry F. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum 2002;46:704-13.
30. Ryan JM, Barry FP, Murphy JM, Mahon BP. Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) 2005;2:8.